Venus Remedies
BSE 526953
4 stories, newest first.
- Five marketing authorisations secured across four international markets
- Social media posts on special window for re-lodgement of transfer requests of physical shares
- Board meeting on 26 October 2026 to consider and approve unaudited Q2 results
- Corporate Identification Number Changed After Object Clause Alteration
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.